PTC Therapeutics, Inc.
PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS FOR TREATING FAMILIAL DYSAUTONOMIA
Last updated:
Abstract:
The present description relates to compounds of formula (I) useful for improving pre-mRNA splicing in a cell. In particular, another aspect described herein relates to substituted pyrrolo[2,3-d]pyrimidine compounds, forms, and pharmaceutical compositions thereof and methods of use for treating or ameliorating familial dysautonomia. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
10 Feb 2020
Issue date:
5 May 2022